Zdrowie i gospodarka · 18/07/2012

FDA Announces Grant Funds for Patient-Based Registry to Study Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis

The FDA is providing grant funding to support the development of a patient registry to investigate the link between gadolinium-based contrast agents and nephrogenic systemic fibrosis, with the ultimate goal of ensuring the safe use of these agents in medical imaging procedures.